Author(s): BARBOSA, A. de O.; GAVA, D.; TOCHETTO, C.; RIBEIRO, L. C.; BASTOS, A. P. A.; MORES, M. A. Z.; SCHAEFER, R.; LIMA, M. de

Summary: Abstract: Senecavirus A (SVA) is a picornavirus that is endemic in swine, causing a vesicular disease clinically indistinguishable from other vesicular diseases, like foot-and-mouth disease. The widespread viral circulation, constant evolution, and economic losses caused to the swine industry emphasize the need for measures to control the agent. In this study, we evaluated the immunogenicity of a whole-virus-inactivated vaccine using a representative contemporary Brazilian SVA strain in Balb/ByJ mice. The animals were vaccinated with two doses by an intramuscular route. The humoral response induced by the vaccination was evaluated by an in-house ELISA assay for IgG detection. The cellular response was assessed by flow cytometry after in vitro SVA stimulation in splenocyte cultures from vaccinated and non-vaccinated groups. Protection against SVA was assessed in the experimental groups following an oral challenge with the homologous virus. The vaccination induced high levels of IgG antibodies and the proliferation of CD45R/B220+sIgM+, CD3e+CD69+, and CD3e+CD4+CD44+CD62L? cells. These results indicate the immunogenicity and safety of the vaccine formulation in a murine model and the induction of humoral and cellular response against SVA.

Publication year: 2024

Types of publication: Journal article

Unit: Embrapa Swine & Poultry

Keywords: Cepa representativa, Inactivated vaccines, Representative strain, Senecavirus A, Vacina Inativada